Disease-Oriented Approach to the Discovery of Novel Vaccines

The Vaccine Book

Volumn , Issue , 2003, Pages 139-147

  Weiser, Jeffrey N ^a   Tuomanen, Elaine I ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 44449177002     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012107258-2/50012-3     Document Type: Chapter

References (26)

1. Andersson I., Rosen V., Hakansson A., Aniansson G., Hansson C., Andersson B., Nylen O., Sabbharwal H., Svanborg C. Antibodies to pneumococcal polysaccharides in human milk: Lack of relationship to colonization and acute otitis media. Ped. Infect. Dis. J. 1996, 15:498-507.
2. Bartlett J., Mundy L. Community-acquired pneumonia. New England J. Medicine 1995, 333:1618-1624.
3. Briles D.E., Forman C., Hudak S., Claflin J.L. Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae. J. Exp. Med. 1982, 156:1177-1185.
4. Briles D.E., Forman C., Hudak S., Claflin J.L. The effects of idiotype on the ability of IgG1 anti-phosphorylcholine antibodies to protect mice from fatal infection with Streptococcus pneumoniae. Eur. J. Immunol. 1984, 14:1027-1030.
5. Briles D.E., Scott G., Gray B., Crain M.J., Blaese M., Nahm M., Scott V., Haber P. Naturally occurring antibodies to phosphocholine as a potential index of antibody responsiveness to polysaccharides. J. Infect. Dis. 1987, 155:1307-1314.
6. Cox A., Howard M., Brisson J., van der Zwan M., Thibault P., Perry M., Inzana T. Structural analysis of the phase-variable lipooligosaccharide from Haemophilus somnus strain 738. Eur. J. Biochem. 1998, 253:507-516.
7. Cundell D.R., Gerard N.P., Gerard C., Idanpaan-Heikkila I., Tuomanen E.I. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 1995, 377:435-438.
8. Deutsch J., Salman M., Rottem S. An unusual polar lipid from the cell membrane of Mycoplasma fermentans. Eur. J. Biochem. 1995, 227:897-902.
9. Fueyo J., Crabtree J., Weiser J. A genomic approach to identify bacterial genes required for survival in specific host environments. International Conference on Microbial and Model Genomes 2000.
10. Gillespie S.H., Ainscough S., Dickens A., Lewin J. Phosphorylcholine-containing antigens in bacteria from the mouth and respiratory tract. J. Med. Microbiol. 1996, 44:35-40.
11. Kim J., Weiser J. Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae. J. Infect. Dis. 1998, 177:368-377.
12. Kolberg J., Holby E.A., Jantzen E. Detection of the phosphorylcholine epitope in streptococci, Haemophilus, and pathogenic Neisseriae by immunoblotting. Microb. Pathogen. 1997, 22:321-329.
13. +) antibodies protect CBA/N (xid) mice against infection with Streptococcus pneumoniae but not Trichinella spiralis. Infect. Immun. 1994, 62:1658-1661.
14. Nordenstam G., Andersson B., Briles D., Brooks J.W.J., Oden A., Svanborg A., Eden C.S. High anti-phosphorylcholine antibody levels and mortality associated with pneumonia. Scand. J. Infect. Dis. 1990, 22:187-195.
15. Schenkein H., Barbour S., Berry C., Kipps B., Tew J. Invasion of human vascular endothelial cells by Actinobacillus actinomycetemcomitans via the receptor for plateletactivating factor. Infect. Immun. 2000, 68:5416-5419.
16. Scott M.G., Briles D.E., Shackelford P.G., Smith D.S., Nahm M.H. Human antibodies to phosphocholine. IgG anti-PC antibodies express restricted numbers of V and C regions. J. Immunol. 1987, 138:3325-3331.
17. Serino L., Virji M. Phosphorylcholine decoration of lipopolysaccharide differentiates commensal Neisseriae from pathogenic strains: Identification of licA-type gehes in commensal Neisseriae. Mol. Microbiol. 2000, 35:1550-1559.
18. Swords W., Buscher B., Ver Steeg Ii K., Preston A., Nichols W., Weiser J., Gibson B., Apicella M. Non-typeable Haemophilus influenzae adhere to and invade human bronchial epithelial cells via an interaction of lipooligosaccharide with the PAF receptor. Mol. Microbiol. 2000, 37:13-27.
19. Szalai A.J., Briles D.E., Volanakis J.E. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice. J. Immunol. 1995, 155:2557-2563.
20. Trolle S., Chachaty E., Kassis-Chikhani N., Wang C., Fattal E., Couvreur P., Diamond B., Alonso J., Andremont A. Intranasal immunization with protein-linked phosphorylcholine protects mice against a lethal intranasal challenge with Streptococcus pneumoniae. Vaccine 2000, 118:2991-2998.
21. Virji M., Weiser J., Lindberg A., Moxon E. Antigenic similarities in lipopolysaccharides of Haemophilus and Neisseria and expression of a digalactoside structure also present on human cells. Microb. Pathogen. 1990, 9:441-450.
22. Weiser J.N., Goldberg J.B., Pan N., Wilson L., Virji M. The phosphorylcholine epitope undergoes phase variation on a 43 kD protein in Pseudomonas aeruginosa and on pili of pathogenic Neisseria. Infect. Immun. 1998, 66:4263-4267.
23. Weiser J.N., Gotschlich E.C. Outer membrane protein A (OmpA) contributes to serum resistance and pathogenicity of Escherichia coli K-1. Infect. Immun. 1991, 59:2252-2258.
24. Weiser J.N., Pan N., McGowan K.L., Musher D., Martin A., Richards J.C. Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein. J. Exp. Med. 1998, 187:631-640.
25. Weiser J.N., Shchepetov M., Chong S.T.H. Decoration of lipopolysaccaride with phosphorylcholine: A phase-variable characteristic of Haemophilus influenzae. Infect. Immun. 1997, 65:943-950.
26. Zhang J.-R., Idanpaan-Heikkila I., Fischer W., Tuomanen E. Pneumococcal licD2 gene is involved in phosphorylcholine metabolism. Mol. Microbiol. 1999, 31:1477-1488.